FDA inspection
Catalyst Pharmaceuticals, Inc.: FDA inspection ending Jun 22, 2023
FDA inspection 1209618 · No Action Indicated (NAI) · Coral Gables, FL
Key facts
| Inspection ID | 1209618 |
|---|---|
| Firm | Catalyst Pharmaceuticals, Inc. |
| FEI number | 3010862019 |
| Address | 355 Alhambra Cir Ste 801 |
| City | Coral Gables |
| State | FL |
| ZIP | 33134 |
| Country | United States |
| Fiscal year | 2023 |
| Inspection end date | Jun 22, 2023 |
| Classification | No Action Indicated (NAI) |
| Project area | Bioresearch Monitoring |
| Product type | Drugs |
At a glance
- None Citations
- None Posted citations
- No Warning letter followed
- No Form FDA 483 issued
- No Establishment inspection report (EIR) exists
- 1–9 Inspections at this FEI
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About FDA inspections
FDA inspections are classified as No Action Indicated (NAI), Voluntary Action Indicated (VAI) or Official Action Indicated (OAI). Inspections of individual clinical investigators are not published here.
Source: U.S. Food and Drug Administration (FDA), inspection classification data